Care for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Fibromyalgia, and or Multiple Chemical Sensitivities (MCS)? It is still over the horizon and a large number of people are waiting for something that might not ever be made available to them. Many people have waited decades for treatments that have yet to materialize. The future is far away.

A Clinical Tool for Health Care Providers

Are you seeing patients with persistent fatigue, post-exertional symptom worsening, cognitive impairment, dizziness, or chronic pain— possibly following a viral illness or COVID-19 infection?

Many of these patients may be living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Postural Orthostatic Tachycardia Syndrome (POTS), or Fibromyalgia -conditions that are common, often disabling, and frequently under-recognized in primary care.

Over 500,000 Canadians may be living with ME/CFS. Up to 80% of people with ME/CFS report onset following an acute viral-like illness, including Covid-19.

A Simple Ask